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Abstract 
A series of 2′-heterocyclic derivatives of 5-phenyl-2,5′-1H-bibenzimidazoles were evaluated for 
topoisomerase I poisoning activity and cytotoxicity. Topo I poisoning activity was associated with 2′-
derivatives that possessed a hydrogen atom capable of hydrogen bond formation, suggesting that the 
interatomic distances between such hydrogen atoms and the heteroatoms on the adjacent 
benzimidazole influence activity. 
 
